Squarepoint Ops LLC Provention Bio, Inc. Transaction History

Squarepoint Ops LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $190,842 - $689,597	-28,484 Reduced 63.44%	16,415 $395,000
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $202,943 - $474,582	44,899 New	44,899 $474,000
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $105,366 - $155,071	-18,616 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $124,913 - $205,520	18,616 New	18,616 $157,000
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $782,286 - $1.5 Million	-77,301 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$11.79 - $18.94 $911,378 - $1.46 Million	77,301 New	77,301 $1.31 Million
Q2 2020 Aug 14, 2020	SELL	$7.81 - $17.0 $150,592 - $327,794	-19,282 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.42 - $17.75 $22,330 - $73,130	4,120 Added 27.17%	19,282 $177,000
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $7,311 - $18,654	1,252 Added 9.0%	15,162 $226,000
Q3 2019 Nov 14, 2019	BUY	$6.83 - $13.0 $95,005 - $180,830	13,910 New	13,910 $95,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.